An Overview of Central Nervous System Tumours

Brian Thabile Flepisi, Marissa Balmith


Central nervous system (CNS) tumours refer to tumours that occur in the tissues of the brain and/or spinal cord. These tumours arise as a result of abnormal growth of cells and may begin in different parts of the brain or spinal cord. There are many types of CNS tumours, which are further divided into subtypes. Despite decades of research conducted, CNS tumours remain among the deadliest of all cancers. It is most often challenging to treat these tumours, due to the risks involved, and biological characteristics associated with them. The classification, grading, and characterisation of CNS tumour plays a pivotal role in the management thereof. The current review provides an overview of CNS tumours, classification, grading and treatment, as well as their characterisation with specific focus on gliomas, ependymomas, oligodendrogliomas, meningiomas, medulloblastomas, schwannomas, gangliogliomas, and craniopharyngiomas.


Doi: 10.28991/SciMedJ-2021-0304-8

Full Text: PDF


Central Nervous System; Tumours; Gliomas; Astrocytomas; Ependymomas; Meningiomas; Medulloblastomas; Schwannomas; Gangliogliomas; Craniopharyngioma.


Cojocaru, E., Mihăilă, D., Leon-Constantin, M. M., Cobzaru, R. G., Rîpă, C. V., Trandafirescu, M. F., & Trandafir, L. M. (2019). Update in pediatric primary brain tumors - from histology to genetically defined tumors. Romanian journal of morphology and embryology, 60(3):761—767. PMID: 31912084.

Reardon, D. A., Rich, J. N., Friedman, H. S., & Bigner, D. D. (2006). Recent advances in the treatment of malignant astrocytoma. Journal of Clinical Oncology, 24(8):1253–65. doi:10.1200/JCO.2005.04.5302.

Tohme, S., Simmons, R. L., & Tsung, A. (2017). Surgery for Cancer: A Trigger for Metastases. Cancer Research, 77(7):1548–1552. doi:10.1158/0008-5472.CAN-16-1536.

Gonzalez,J., & Gilbert, M. R. (2005). Treatment of astrocytomas. Current Opinion in Neurology,18(6):632–8. doi:10.1097/01.wco.0000191510.14627.d2.

Liu, R., Page M., Solheim K., Fox S., & Chang S. M. (2009). Quality of life in adults with brain tumors: Current knowledge and future directions. Neuro Oncology, 11(3):330–9. doi:10.1215/15228517-2008-093.

Kelly, P. (2010). Gliomas: Survival, origin and early detection. Surgical Neurology International, 1(1):96. doi:10.4103/2152-7806.74243.

Baskar,R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K. W. (2014). Biological response of cancer cells to radiation treatment. Frontiers in Molecular Biosciences, 1(24):1–9. doi:10.3389/fmolb.2014.00024.

Mohan, G., Hamna, A., Jijo, A. J., Devi, S., , Narayanasamy, A., & Vellingiri, B. (2019).. Recent advances in radiotherapy and its associated side effects in cancer—a review. The Journal of Basic and Applied Zoology, 80(1):1–10. doi:10.1186/s41936-019-0083-5.

Lauber, K., Ernst, A., Orth, M., Herrmann, M., & Belka, C. (2012). Dying cell clearance and its impact on the outcome of tumor radiotherapy. Frontiers in Oncology, 2(116):1–14. doi:10.3389/fonc.2012.00116.

Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K. W. (2012). Cancer and radiation therapy: Current advances and future directions. International Journal of Medical Sciences, 9(3):193–9. doi:10.7150/ijms.3635.

Hoffman, C. (2007). Benefits of complementary therapies. Breast Cancer Research, 9(S2):1–3. doi:10.1186/bcr1807.

Bhowmik, A., Khan, R., Ghosh, M. K. (2015). Blood brain barrier: A challenge for effectual therapy of brain tumors. Biomedical Research International, 2015:1–20. doi:10.1155/2015/320941.

K. (2012). Chemotherapy and Dietary Phytochemical Agents. Chemotherapy Research and Practice, 2012:1–11. doi:10.1155/2012/282570.

Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., & Astsaturov, I. (2010). Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? Cancer Biology and Therapy, 10(9):839–53. doi:10.4161/cbt.10.9.13738.

Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmacuetical Bulletin. 7(3):339–48. doi:10.15171/apb.2017.041.

Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., et al. (2014). Drug resistance in cancer: An overview. Cancers (Basel). 6(3):1769–92. doi:10.3390/cancers6031769.

Jäkel, S., & Dimou, L. (2017). Glial cells and their function in the adult brain: A journey through the history of their ablation. Frontiers in Cellular Neuroscience, 11(24), 1–17. doi:10.3389/fncel.2017.00024.

Nirzhor, S. S. R., Khan, R. I., Neelotpol, S. (2018) The biology of glial cells and their complex roles in Alzheimer’s disease: New opportunities in therapy. Biomolecules. 8(3):1–21. doi:10.3390/biom8030093.

Davis, M. E. (2016). Glioblastoma: Overview of disease and treatment. Clinical Journal of Oncology Nursing, 20(5), S2–S8. doi:10.1188/16.CJON.S1.2-8.

Zong, H., Parada, L. F., & Baker, S. J. (2015). Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harbor Perspectives in Biology, 7(5), 1–13. doi:10.1101/cshperspect.a020610.

Wesseling, P., & Capper, D. (2018) WHO 2016 Classification of gliomas. Neuropathology and Applied Neurobiology,44(2):139–50. doi: 10.1111/nan.12432.

Rahmani, R., Tomlinson, S. B., Santangelo, G., Warren, K. T., Schmidt, T., Walter, K. A., & Vates, G. E. (2019). Risk factors associated with early adverse outcomes following craniotomy for malignant glioma in older adults. Journal of Geriatric Oncology, 11(4), 694–700. doi:10.1016/j.jgo.2019.10.019.

Walker, C., Baborie, A., Crooks, D., Wilkins, S., & Jenkinson, M. D. (2011). Biology, genetics and imaging of glial cell tumours. British Journal of Radiology, 84(2), S90–S106. doi:10.1259/bjr/2343.

Thurtle, D. R., Greenberg, D. C., Lee, L. S., Huang, H. H., Pharoah, P. D., & Gnanapragasam, V. J. (2019). Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the predict prostate multivariable model. PLoS Medicine, 16(3), 1–19. doi:10.1371/journal.pmed.1002758.

Walker, D. G., & Kaye, A. H. (2001). Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: A review. Australasian Radiology, 45, 472–482. doi:10.1093/med/9780198570677.003.0295.

Larjavaara, S., Mäntylä, R., Salminen, T., Haapasalo, H., Raitanen, J., Jääskeläinen, J., & Auvinen, A. (2007). Incidence of gliomas by anatomic location. Neuro-Oncology, 9(3), 319–325. doi:10.1215/15228517-2007-016.

Sidoryk-Wegrzynowicz, M., & Aschner, M. (2013) Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacology and Toxicology, 14(23):1–10. doi:10.1186/2050-6511-14-23.

Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001). Glial cell influence on the human blood-brain barrier. Glia, 36(2), 145–155. doi:10.1002/glia.1104.

Bello, L., Duffau, H., & Soffietti, R. (2012). Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology, 14, 55–64. doi:10.1093/neuonc/nos199.

Cserni, G. (2002). Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. Journal of Clinical Pathology, 55(4), 293–297. doi:10.1136/jcp.55.4.293.

Park, J. H., Jung, N., Kang, S. J., Kim, H. S., Kim, E., Lee, H. J., Jung, H. R., Choe, M., & Shim, Y. J. (2019). Survival and Prognosis of Patients with Pilocytic Astrocytoma: A Single-Center Study. Brain Tumor Research and Treatment, 7(2), 92–97. doi:10.14791/btrt.2019.7.e36.

Khaldi, A., Griauzde, J., DiPatri, A., Prabhu, V. C. (2012). Pilocytic Astrocytoma : A Comprehensive Review. Contemporary Neurosurgery, 33(10):1–6. doi: 10.1097/01.CNE.0000406545.01381.fc.

Findik, S. (2017). Primary Pilocytic Astrocytoma with Malign Transformation. Journal of Neurology & Stroke, 6(6), 4–6. doi:10.15406/jnsk.2017.06.00222.

Collins, V. P., Jones, D. T. W., & Giannini, C. (2015). Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 775–788. doi:10.1007/s00401-015-1410-7.

Fernandez, C., Figarella-Branger, D., Girard, N., Bouvier-Labit, C., Gouvernet, J., Paredes, A. P., Lena, G., Sindou, M. P., Rilliet, B., De Tribolet, N., Tomita, T., & Rutka, J. T. (2003). Pilocytic astrocytomas in children: Prognostic factors - A retrospective study of 80 cases. Neurosurgery, 53(3), 544–555. doi:10.1227/01.NEU.0000079330.01541.6E.

Han, T. (2017). Subependymal giant cell astrocytoma. Chinese Journal of Contemporary Neurology and Neurosurgery, 17(4), 310. doi:10.3969/j.issn.1672-6731.2017.04.015.

Grajkowska, W., Kotulska, K., Jurkiewicz, E., Roszkowski, M., Daszkiewicz, P., Jóźwiak, S., & Matyja, E. (2011). Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas. Folia Neuropathologica, 49(1), 39–46. PMID: 21455842.

Mei, G. H., Liu, X. X., Zhou, P., & Shen, M. (2017). Clinical and imaging features of subependymal giant cell astrocytoma: Report of 20 cases. Chinese Neurosurgical Journal, 3(1), 1–7. doi:10.1186/s41016-017-0077-4.

Ahmed, N., Alam, S., Islam, K. M. T., Haque, M., & Ahsan, A. (2020). Subependymal giant cell astrocytoma associated with hyperproteinorrhachia , presented with vp shunt malfunction : a rare clinical entity. Journal of Neurology & Stroke, 10(3), 97–99. doi:10.15406/jnsk.2020.10.00418.

Nowaczewska, M., & Kaźmierczak, H. (2020). Cerebral blood flow in low intracranial pressure headaches—what is known? Brain Sciences, 10(2), 1–9. doi:10.3390/brainsci10010002.

Chan, M., & Amin-Hanjani, S. (2010). Cerebrospinal Fluid and its Abnormalities. Encyclopedia of Life Sciences, 1–9. doi:10.1002/9780470015902.a0002191.pub2.

Abid, M., Haroon, S., Memon, A. H., Ahmad, Z., Hasan, S. H. (2018). Pleomorphic xanthoastrocytoma: Clinicopathological spectrum of an intriguing neoplasm. Pakistan Journal of Medical Sciences. 34(2):277–81. doi:10.12669/pjms.342.14663.

Choudry, U. K., Khan, S. A., Qureshi, A., & Bari, E. (2016). Primary anaplastic pleomorphic xanthoastrocytoma in adults. Case report and review of literature. International Journal of Surgery Case Reports, 27, 183–188. doi:10.1016/j.ijscr.2016.08.022.

Watanabe, N., Ishikawa, E., Kohzuki, H., Sakamoto, N., Zaboronok, A., Matsuda, M., Shibuya, M., & Matsumura, A. (2020). Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: Case report. BMC Neurology, 20(1), 7–11. doi:10.1186/s12883-020-1601-2.

Shaikh, N., Brahmbhatt, N., Kruser, T. J., Kam, K. L., Appin, C. L., Wadhwani, N., Chandler, J., Kumthekar, P., & Lukas, R. V. (2019). Pleomorphic xanthoastrocytoma: a brief review. CNS Oncology, 8(3), CNS39. doi:10.2217/cns-2019-0009.

Cristiane M. Ida, Fausto J. Rodriguez, Peter C. Burger, Alissa A. Caron, S. M., Jenkins, Grant M. Spears, Dawn L. Aranguren, Daniel H. Lachance, and C., & Giannini. (2015). Pleomorphic Xanthoastrocytoma: Natural History and LongTerm Follow-Up. Brain Pathology, 25(5), 575–586. doi:10.1111/bpa.12217.Pleomorphic.

Zhang, S., & William, C. (2020). Educational Case: Histologic and Molecular Features of Diffuse Gliomas. Academic Pathology, 7, 1–12. doi:10.1177/2374289520914021.

Ryall, S., Tabori, U., & Hawkins, C. (2017). A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment. Brain Tumor Pathology, 34(2), 51–61. doi:10.1007/s10014-017-0282-z.

Ichimura, K., Narita, Y., & Hawkins, C. E. (2015). Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 789–808. doi:1007/s00401-015-1439-7.

Wesseling, P., Kros, J. M., & Jeuken, J. W. M. (2011). The pathological diagnosis of diffuse gliomas: Towards a smart synthesis of microscopic and molecular information in a multidisciplinary context. Diagnostic Histopathology, 17(11), 486–494. doi:10.1016/j.mpdhp.2011.08.005.

Kaminska, B., Czapski, B., Guzik, R., Król, S. K., & Gielniewski, B. (2019). Consequences of IDH1/2 mutations in gliomas and an assessment of inhibitors targeting mutated IDH proteins. Molecules, 24(5), 1–17. doi:10.3390/molecules24050968.

Liu, Y., Lang, F., Chou, F. J., Zaghloul, K. A., & Yang, C. (2020). Isocitrate dehydrogenase mutations in glioma: Genetics, biochemistry, and clinical indications. Biomedicines, 8(9), 1–19. doi:10.3390/BIOMEDICINES8090294.

Delgado-López, P. D., Corrales-García, E. M., Martino, J., Lastra-Aras, E., & Dueñas-Polo, M. T. (2017). Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clinical and Translational Oncology, 19(8), 931–944. doi:10.1007/s12094-017-1631-4.

Dotson, J., Nijim, A., Denning, K. L., Shweihat, Y., & Lebowicz, Y. (2018). A Rare Case of Metastases from a High-grade Astrocytoma to the Pleura, Bones, and Liver within Six Months of Diagnosis. Cureus, 10(8), 1–6. doi:10.7759/cureus.3234.

Dong, X., Noorbakhsh, A., Hirshman, B. R., Zhou, T., Tang, J. A., Chang, D. C., Carter, B. S., & Chen, C. C. (2014). Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis. Neuro-Oncology Practice, 3(1), 29–38. doi:10.1093/nop/npv016.

Grimm, S. A., & Chamberlain, M. C. (2016). Anaplastic astrocytoma. CNS Oncology, 5(3), 145–157. doi:10.2217/cns-2016-0002.

Collins, V. P. (2004). Brain tumours: Classification and genes. Neurology in Practice, 75(2), i2–i11. doi:10.1136/jnnp.2004.040337.

Haase, S., Nuñez, F. M., Gauss, J. C., Thompson, S., Brumley, E., Lowenstein, P., & Castro, M. G. (2020). Hemispherical pediatric high-grade glioma: Molecular basis and therapeutic opportunities. International Journal of Molecular Sciences, 21(24), 1–25. doi:10.3390/ijms21249654.

Dirven, L., Sizoo, E. M., & Taphoorn, M. J. B. (2015). Anaplastic gliomas: end-of-life care recommendations. CNS Oncology, 4(5), 357–365. doi:10.2217/cns.15.31.

Urbanska, K., Sokolowska, J., Szmidt, M., & Sysa, P. (2014). Glioblastoma multiforme - An overview. Wspolczesna Onkologia, 18(5), 307–312. doi:10.5114/wo.2014.40559.

Witoonpanich, P., Bamrungrak, K., Jinawath, A., Wongwaisayawan, S., Phudhichareonrat, S., & Witoonpanich, R. (2011). Glioblastoma multiforme at the corpus callosum with spinal leptomeningeal metastasis. Clinical Neurology and Neurosurgery, 113(5), 407–410. doi:10.1016/j.clineuro.2010.12.001.

Robert, M. C., & Wastie, M. E. (2008). Glioblastoma multiforme: A rare manifestation of extensive liver and bone metastases. Biomedical Imaging and Intervention Journal, 4(1), 2–5. doi:10.2349/biij.4.1.e3.

Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., & Simjee, S. U. (2017). Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific Journal of Cancer Prevention, 18(1), 3–9. doi:10.22034/APJCP.2017.18.1.3.

Minniti, G., Muni, R., Lanzetta, G., Marchetti, P., & Enrici, R. M. (2009). Chemotherapy for Glioblastoma: Current Treatment and Future Perspectives for Cytotoxic and Targeted Agents. Anticancer Research, 29, 5171–5184. PMID: 20044633.

Hadziahmetovic, M., Shirai, K., & Chakravarti, A. (2011). Recent advancements in multimodality treatment of gliomas. Future oncology (London, England), 7(10), 1169–1183. doi:10.2217/fon.11.102.

Wu, J., Armstrong, T. S., & Gilbert, M. R. (2016). Biology and management of ependymomas. Neuro-Oncology, 18(7), 902–913. doi:10.1093/neuonc/now016.

Brinker, T., Stopa, E., Morrison, J., & Klinge, P. (2014). A new look at cerebrospinal fluid circulation. Fluids and Barriers of the CNS, 11(1), 1–16. doi:10.1186/2045-8118-11-10.

Fame, R. M., Cortés-Campos, C., & Sive, H. L. (2020). Brain Ventricular System and Cerebrospinal Fluid Development and Function: Light at the End of the Tube: A Primer with Latest Insights. BioEssays, 42(3), 1–15. doi:10.1002/bies.201900186.

Stiller, C. A., Bayne, A. M., Chakrabarty, A., Kenny, T., & Chumas, P. (2019). Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: Population-based study. BMC Cancer, 19(1), 1–15. doi:10.1186/s12885-019-5344-7.

Purdy, E., Johnston, D. L., Bartels, U., Fryer, C., Carret, A. S., Crooks, B., Eisenstat, D. D., Lafay-Cousin, L., Larouche, V., Wilson, B., Zelcer, S., Silva, M., Bouffet, E., Keene, D., & Strother, D. R. (2014). Ependymoma in children under the age of 3 years: A report from the Canadian Pediatric Brain Tumour Consortium. Journal of Neuro-Oncology, 117(2), 359–364. doi:10.1007/s11060-014-1396-3.

American Brain Tumour Association. Ependymoma. Available online: ependymoma-brochure.pdf (accessed on March 2021).

Fernández, I. S., & Loddenkemper, T. (2017). Seizures caused by brain tumors in children. Seizure, 44, 98–107. doi:10.1016/j.seizure.2016.11.028.

Sasaki, A., Hirato, J., Hirose, T., Fukuoka, K., Kanemura, Y., Hashimoto, N., Kodama, Y., Ichimura, K., Sakamoto, H., & Nishikawa, R. (2019). Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome. Brain Tumor Pathology, 36(2), 92–101. doi:10.1007/s10014-019-00338-x.

Jain, A., Amin, A. G., Jain, P., Burger, P., Jallo, G. I., Lim, M., & Bettegowda, C. (2012). Subependymoma: Clinical features and surgical outcomes. Neurological Research, 34(7), 677–684. doi:10.1179/1743132812Y.0000000064.

Scheinker, I. M. (1944). Subependymoma: a newly recognized tumor of subependymal derivation. 1–9. doi:10.3171/jns.1945.2.3.0232.

Koutourousiou, M., Georgakoulias, N., Kontogeorgos, G., & Seretis, A. (2009). Subependymomas of the lateral ventricle: Tumor recurrence correlated with increased Ki-67 labeling index. Neurology India, 57(2), 191–193. doi:10.4103/0028-3886.51293.

Ragel, B. T., Osborn, A. G., Whang, K., Townsend, J. J., Jensen, R. L., & Couldwell, W. T. (2006). Subependymomas: An analysis of clinical and imaging features. Neurosurgery, 58(5), 881–889. doi:10.1227/01.NEU.0000209928.04532.09.

Smith, A. B., Smirniotopoulos, J. G., & Horkanyne-Szakaly, I. (2013). From the radiologic pathology archives: Intraventricular neoplasms: Radiologic-pathologic correlation. Radiographics, 33(1), 151–154. doi:10.1148/rg.331125192.

Kim, Y., Lee, S. Y., Yi, K. S., Cha, S. H., Gang, M. H., Cho, B. S., & Lee, Y. M. (2014). Infratentorial and intraparenchymal subependymoma in the cerebellum: Case Report. Korean Journal of Radiology, 15(1), 151–155. doi:10.3348/kjr.2014.15.1.151.

Iddrissu, M., Dakurah, T., & Wepeba, G. (2006). Anaplastic ependymoma of the fourth ventricle causing obstrictive hydrocephalus. Ghana Medical Journal, 39(1), 33–36. doi:10.4314/gmj.v39i1.35979.

Fonseca, L., Cicuendez, M., Martínez-Ricarte, F., Martínez-Saez, E., Cordero, E., & Bescos, A. (2019). A rare case of an intramedullary metastasis of a myxopapillary ependymoma. Surgical Neurology International, 10(83), 1–4. doi:10.25259/sni-96-2019.

Celano, E., Salehani, A., Malcolm, J. G., Reinertsen, E., Hadjipanayis, C. G., Sinai, M., Israel, B., & Ambulatory, P. (2016). Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neurooncol, 128(3), 377–386. doi:10.1007/s11060-016-2135-8.Spinal.

Koeller, K. K., Rosenblum, R. S., & Morrison, A. L. (2000). Neoplasms of the Spinal Cord and Filum Terminale: Radiologic-Pathologic Correlation. Radiographics, 20(6), 1721–1749. doi:10.1007/978-3-540-85019-9_15.

Bandopadhayay, P., Silvera, V. M., Ciarlini, P. D. S. C., Malkin, H., Bi, W. L., Bergthold, G., Faisal, A. M., Ullrich, N. J., Marcus, K., Scott, R. M., Beroukhim, R., Manley, P. E., Chi, S. N., Ligon, K. L., Goumnerova, L. C., & Kieran, M. W. (2016). Myxopapillary ependymomas in children: imaging, treatment and outcomes. Journal of Neuro-Oncology, 126(1), 165–174. doi:10.1007/s11060-015-1955-2.

Carter, M., Nicholson, J., Ross, F., Crolla, J., Allibone, R., Balaji, V., Perry, R., Walker, D., Gilbertson, R., & Ellison, D. (2002). Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. British Journal of Cancer, 86(6), 929–939. doi:10.1038/sj.bjc.6600180.

Shirasawa, H., Ishii, K., Iwanami, A., Mikami, S., Toyama, Y., Matsumoto, M., & Nakamura, M. (2014). Pediatric myxopapillary ependymoma treated with subtotal resection and radiation therapy: A case report and review of the literature. Spinal Cord, 52(SUPPL. 2), 18–20. doi:10.1038/sc.2014.95.

Samartzis, D., Gillis, C. C., Shih, P., Toole, J. E. O., & Fessler, R. G. (2015). Intramedullary Spinal Cord Tumors : Part I - Epidemiology, Pathophysiology, and Diagnosis. Global Spine Journal, 5(5), 425–435. doi:10.1055/s-0035-1549029.

Shinde, S. M., Kumbhar, U. R., Deshmukh, D. B., Gaikwad, D. D., & Grampurohit, N. D. (2013). A review: Ependymomas disease. International Journal of Pharmaceutical and Clinical Research, 5(2), 47–63. ISSN:0975 1556.

Dulai, M. S., Caccamo, D. V., Briley, A. L., Edwards, M. S. B., Fisher, P. G., & Lehman, N. L. (2010). Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain. Journal of Neurosurgery: Pediatrics, 5(5), 511–517. doi:10.3171/2009.12.PEDS09130.

Maity, P., Chaudhuri, Debashis, Chakrabarty, Shubhamitra, Chaudhuri, & Chatterjee, U. (2019). Papillary Ependymoma of the Spinal Cord: A Case Report with Summary of Prior Published Cases. Asian Journal of Neurosurgery, 14(1), 223–226. doi:10.4103/ajns.AJNS.

Sheen Kweh, B. T., Rosenfeld, J., Hunn, M., & Tee, J. W. (2021). The Effects of Surgery and Adjuvant Therapy on Survival Outcomes in Clear Cell Ependymomas: A Systematic Review and Meta-Analysis of Individual Patient Data. World Neurosurgery, 145, 229–240. doi:10.1016/j.wneu.2020.09.044.

Lee, B. H., Kwon, J. T., & Park, Y. S. (2011). Supratentorial clear cell ependymoma Mimicking oligodendroglioma: Case report and review of the literature. Journal of Korean Neurosurgical Society, 50(3), 240–243. doi:10.3340/jkns.2011.50.3.240.

Deb, P., Manu, V., Pradeep, H., & Bhatoe, H. (2011). Intraparenchymal clear cell ependymoma. Journal of Cytology, 28(2), 73–76. doi:10.4103/0970-9371.80747.

Krisht, K. M., & Schmidt, M. H. (2013). Tanycytic Ependymoma: A Challenging Histological Diagnosis. In Case Reports in Neurological Medicine (Vol. 2). doi:10.1155/2013/170791.

Lehman, N. L. (2008). Central nervous system tumors with ependymal features: A broadened spectrum of primarily ependymal differentiation? Journal of Neuropathology and Experimental Neurology, 67(3), 177–188. doi:10.1097/NEN.0b013e31816543a6.

Zhang, S., Wang, X., Zhang, Z., & Chen, Y. (2008). Tanycytic ependymoma arising from the right lateral ventricle: A case report and review of the literature. Neuropathology, 28(4), 427–432. doi:10.1111/j.1440-1789.2007.00857.x.

Lee, J., Chung, S. Y., Han, J. W., Kim, D. S., Kim, J., Moon, J. Y., Yoon, H. I., & Suh, C. O. (2020). Treatment outcome of anaplastic ependymoma under the age of 3 treated by intensity-modulated radiotherapy. Radiation Oncology Journal, 38(1), 26–34. doi:10.3857/roj.2020.00073.

Bansal, K., Kongkham, P., & Rutka, J. T. (2006). Treatment Modalities for Ependymomas in Children. Contemporary Neurosurgery, 28(4), 1–7. doi:10.1097/00029679-200602280-00001.

Wesseling, P., van den Bent, M., & Perry, A. (2015). Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 809–827. doi:10.1007/s00401-015-1424-1.

Smits, M. (2016). Imaging of oligodendroglioma. Br J Radiol, 89(20150857), 1–11. doi:10.1016/B978-0-12-813158-9.00012-8.

Torensma, R. (2018). The dilemma of cure and damage in oligodendroglioma: Ways to tip the balance away from the damage. Cancers, 10(431), 1–10. doi:10.3390/cancers10110431.

Ohgaki, H., & Kleihues, P. (2005). Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology, 64(6), 479–489. doi:10.1093/jnen/64.6.479.

Blakeley, J., & Grossman , S. (2008). Anaplastic Oligodendroglioma. Curr Treat Options Neurol, 10(4), 295–307. doi:10.1007/s11940-008-0032-y.

Burgy, M., Chenard, M. P., Noël, G., Bourahla, K., & Schott, R. (2019). Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: A case report. Journal of Medical Case Reports, 13(1), 1–5. doi:10.1186/s13256-019-2061-4.

Louis, D. N., Holland, E. C., & Cairncross, J. G. (2001). Glioma classification: A molecular reappraisal. American Journal of Pathology, 159(3), 779–786. doi:10.1016/S0002-9440(10)61750-6.

Engelhard, H. H. (2002). Current diagnosis and treatment of oligodendroglioma. Journal of Neurosurgery, 12(2), 1–7. doi:10.3171/foc.2002.12.2.3.

Lee, C. H., Jung, K. W., Yoo, H., Park, S., & Lee, S. H. (2010). Epidemiology of primary brain and central nervous system tumors in Korea. Journal of Korean Neurosurgical Society, 48(2), 145–152. doi:10.3340/jkns.2010.48.2.145.

Yamashima, T. (2009). Human Meninges: Anatomy and Its Role in Meningioma Pathogenesis. Meningiomas, 15–24. doi:10.1007/978-1-84628-784-8_3.

Sun, T., Plutynski, A., Ward, S., & Rubin, J. B. (2015). An integrative view on sex differences in brain tumors. Cellular and Molecular Life Sciences, 72(17), 3323–3342. doi:10.1007/s00018-015-1930-2.

Buerki, R. A., Horbinski, C. M., Kruser, T., Horowitz, P. M., James, C. D., & Lukas, R. V. (2018). An overview of meningiomas. Future Oncology, 14(21), 2161–2177. doi:10.2217/fon-2018-0006.

Harter, P. N., Braun, Y., & Plate, K. H. (2017). Classification of meningiomas-advances and controversies. Chinese Clinical Oncology, 6(2), 1–8. doi:10.21037/cco.2017.05.02.

Simpson D. (1957). The recurrence of intracranial meningiomas after surgical treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 20(1), 22–39. doi:10.1136/jnnp.20.1.22.

Lee, J. H., Kim, O. L., Seo, Y. B., & Choi, J. H. (2017). Prognostic factors of atypical meningioma: Overall survival rate and progression free survival rate. Journal of Korean Neurosurgical Society, 60(6), 661–666. doi:10.3340/jkns.2017.0303.008.

Sharifi, G., Lotfinia, M., Omidbeigi, M., Asaadi, S., & Zerehpoosh, F. B. (2020). Meningothelial meningioma of the oculomotor nerve: A case report and review of the literature. Surgical Neurology International, 11(314), 1–4. doi:10.25259/SNI_312_2020.

Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006). Histological classification and molecular genetics of meningiomas. Lancet Neurology, 5(12), 1045–1054. doi:10.1016/S1474-4422(06)70625-1.

Samundeeswari, R. Kannan, P. (2019). A Retrospective Study of Histopathology and Clinical Correlation of Spinal Meningioma at Thoothukudi Medical. Medical and Dental Research, 5(5), 1–11. doi:10.21276/aimdr.2019.5.5.PT1.

Li, J., Fang, L., Killer, H. E., Flammer, J., Meyer, P., & Neutzner, A. (2013). Meningothelial cells as part of the central nervous system host defence. Biology of the Cell, 105(7), 304–315. doi:10.1111/boc.201300013.

Bhat, A. R., Wani, M. A., Kirmani, A. R., & Ramzan, A. U. (2014). Histological-subtypes and anatomical location correlated in meningeal brain tumors (meningiomas). Journal of Neurosciences in Rural Practice, 5(3), 244–249. doi:10.4103/0976-3147.133568.

Rushing, E. J., Bouffard, J. P., McCall, S., Olsen, C., Mena, H., Sandberg, G. D., & Thompson, L. D. R. (2009). Primary extracranial meningiomas: An analysis of 146 cases. Head and Neck Pathology, 3(2), 116–130. doi:10.1007/s12105-009-0118-1.

Jacobo, J. A., Mamani, R., Jimenez, S. M., Avendaño, J., & Nuñez, S. (2020). Microcystic meningioma associated with other meningioma subtypes: A diagnostic challenge, report of two cases. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management, 19(100548), 1–5. doi:10.1016/j.inat.2019.100548.

Paik, S. S., Jang, S. J., Park, Y. W., Hong, E. K., Park, M. H., & Lee, J. D. (1996). Microcystic meningioma - A case report. In Journal of Korean Medical Science (Vol. 11, Issue 6, pp. 540–543). doi:10.3346/jkms.1996.11.6.540.

Kim, S. H., Kim, D. G., Kim, C. Y., Choe, G., Chang, K. H., & Jung, H. W. (2003). Microcystic Meningioma: The Characteristic Neuroradiologic Findings. Journal of Korean Neurosurgical Society, 34(5), 401-406.

Kim, J. H., Kim, Y. J., Kim, H., Nam, S. H., & Choi, Y. W. (2015). A rare case of transitional meningioma. Archives of Plastic Surgery, 42(3), 375–377. doi:10.5999/aps.2015.42.3.375.

Lee, W., Chang, K. H., Choe, G., Chi, J. G., Chung, C. K., Kim, I. H., Han, M. H., Park, S. W., Shin, S. J., & Koh, Y. H. (2000). MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. American Journal of Neuroradiology, 21(1), 130–132. PMID: 10669237.

Kunimatsu, A., Kunimatsu, N., Kamiya, K., Katsura, M., Mori, H., & Ohtomo, K. (2016). Variants of meningiomas: a review of imaging findings and clinical features. Japanese Journal of Radiology, 34(7), 459–469. doi:10.1007/s11604-016-0550-6.

Mishra, R. K., Vahikar, S. U., Singh, M., Lal, G. N., & Shrivastava, K. (2015). Angiomatous Meningioma Arising in Tonsil : A Rare Tumor at Rare Site. 3(7), 262–265. doi:10.17354/ijss/2015/491.

Liu, Z., Wang, C., Wang, H., Wang, Y., Li, J. Y., & Liu, Y. (2013). Clinical characteristics and treatment of angiomatous meningiomas: A report of 27 cases. International Journal of Clinical and Experimental Pathology, 6(4), 695–702. PMID: 23573316.

Regelsberger, J., Hagel, C., Emami, P., Ries, T., Heese, O., & Westphal, M. (2009). Secretory meningiomas: A benign subgroup causing life-threatening complications. Neuro-Oncology, 11(6), 819–824. doi:10.1215/15228517-2008-109.

Choi, Y.-H., Choi, C.-Y., Lee, C.-H., Koo, H.-W., & Chang, S.-H. (2018). Metaplastic Meningioma Overspreading the Cerebral Convexity. Brain Tumor Research and Treatment, 6(2), 97–100. doi:10.14791/btrt.2018.6.e17.

Tang, H., Sun, H., Chen, H., Gong, Y., Mao, Y., Xie, Q., Xie, L., Zheng, M., Wang, D., Zhu, H., Che, X., Zhong, P., Zheng, K., Li, S., Bao, W., Zhu, J., Wang, X., Feng, X., Chen, X., & Zhou, L. (2013). Clinicopathological analysis of metaplastic meningioma: Report of 15 cases in Huashan Hospital. Chinese Journal of Cancer Research, 25(1), 112–118. doi:10.3978/j.issn.1000-9604.2013.01.10.

Zhu, H. Da, Xie, Q., Gong, Y., Mao, Y., Zhong, P., Hang, F. P., Chen, H., Zheng, M. Z., Tang, H. L., Wang, D. J., Chen, X. C., & Zhou, L. F. (2013). Lymphoplasmacyte-rich meningioma: Our experience with 19 cases and a systematic literature review. International Journal of Clinical and Experimental Medicine, 6(7), 504–515. PMID: 23936588.

Ros-Sanjuan, A., Iglesias-Moroño, S., Carrasco-Brenes, A., Bautista-Ojeda, D., & Arraez-Sanchez, M. A. (2019). Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence. World Neurosurgery, 125, e248–e256. doi:10.1016/j.wneu.2019.01.056.

Brokinkel, B., Hess, K., & Mawrin, C. (2017). Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: A systematic review. Neuro-Oncology, 19(10), 1298–1307. doi:10.1093/neuonc/nox071.

Backer-Grøndahl, T., Moen, B. H., & Torp, S. H. (2012). The histopathological spectrum of human meningiomas. International Journal of Clinical and Experimental Pathology, 5(3), 231–242. PMID: 22558478.

Zhang, H., Ma, L., Wang, Y. bo, Shu, C., Kuang, W., Huang, Y. an, Dong, L. qiang, & Cheng, G. ge. (2017). Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence. World Neurosurgery, 97, 693-700.e11. doi:10.1016/j.wneu.2016.10.010.

Lee, W., Chang, K. H., Choe, G., Chi, J. G., Chung, C. K., Kim, I. H., Han, M. H., Park, S. W., Shin, S. J., & Koh, Y. H. (2000). MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. American Journal of Neuroradiology, 21(1), 130–132. PMID: 10669237.

Prokopienko, M., Wierzba-Bobrowicz, T., Grajkowska, W., Stępień, T., & Sobstyl, M. (2020). Chordoid Meningioma: Case Report and Review of the Literature. Neurosurgery - Cases and Reviews, 3(2), 1–5. doi:10.23937/2643-4474/1710045.

Kepes, J. J., Chen, W. Y., Connors, M. H., & Vogel, F. S. (1988). “Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the castleman syndrome. A report of seven cases. Cancer, 62(2), 391–406. doi:10.1002/1097-0142(19880715)62:2<391::AID-CNCR2820620226>3.0.CO;2-7.

Hasegawa, S., Yoshioka, S., Urabe, S., & Kuratsu, J. I. (2006). Rapidly enlarging chordoid meningioma with abundant mucin production. Neuropathology, 26(5), 438–441. doi:10.1111/j.1440-1789.2006.00708.x.

Loewenstern, J., Shuman, W., Rutland, J. W., Kessler, R. A., Kohli, K. M., Umphlett, M., Pain, M., Bederson, J., Fowkes, M., & Shrivastava, R. K. (2019). Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma after Initial Gross Total Resection. World Neurosurgery, 128, e148–e156. doi:10.1016/j.wneu.2019.04.069.

Rogers, L., Barani, I., Chamberlain, M., Kaley, T. J., McDermott, M., Raizer, J., Schiff, D., Weber, D. C., Wen, P. Y., & Vogelbaum, M. A. (2015). Meningiomas: Knowledge base, treatment outcomes, and uncertainties. A RANO review. Journal of Neurosurgery, 122(1), 4–23. doi:10.3171/2014.7.JNS131644.

Millard, M. E., & De Braganca, K. C. (2016). Medulloblastoma. J Child Neurol, 31(12), 1341–1353. doi:10.1177/0883073815600866.Medulloblastoma.

Kijima, N., & Kanemura, Y. (2016). Molecular classification of medulloblastoma. Neurologia Medico-Chirurgica, 56(11), 687–697. doi:10.2176/nmc.ra.2016-0016.

Patay, Z., DeSain, L. A., Hwang, S. N., Coan, A., Li, Y., & Ellison, D. W. (2015). MR imaging characteristics of wingless-type-subgroup pediatric medulloblastoma. American Journal of Neuroradiology, 36(12), 2386–2393. doi:10.3174/ajnr.A4495.

Menyhárt, O., & Győrffy, B. (2019). Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Annals of Clinical and Translational Neurology, 6(5), 990–1005. doi:10.1002/acn3.762.

Ramaswamy, V., Nör, C., & Taylor, M. D. (2016). P53 and Meduloblastoma. Cold Spring Harbor Perspectives in Medicine, 6(2), 1–9. doi:10.1101/cshperspect.a026278.

Juraschka, K., & Taylor, M. D. (2019). Medulloblastoma in the age of molecular subgroups: A review: JNSPG 75th Anniversary invited review article. Journal of Neurosurgery: Pediatrics, 24(4), 353–363. doi:10.3171/2019.5.PEDS18381.

Zou, H., Poore, B., Broniscer, A., Pollack, I. F., & Hu, B. (2020). Molecular heterogeneity and cellular diversity: Implications for precision treatment in medulloblastoma. Cancers, 12(3). doi:10.3390/cancers1203064.

Vaidyanathan, G., Gururangan, S., Bigner, D., Zalutsky, M., Robert, P., & Brain, T. (2014). Medulloblastoma. Neuro-Oncology, 16(1), 71–96. doi:10.1093/neuonc/nou074.

Thomas, A., & Noël, G. (2019). Medulloblastoma: Optimizing care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare, 12, 335–347. doi:10.2147/JMDH.S167808.

De Braganca, K. C., & Packer, R. J. (2016). Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET). Curr Treat Options Neurol, 15(5), 593–606. doi:10.1007/s11940-013-0255-4.Treatment.

Ortega-Merchan, M. P., Reyes, F., Mejía, J. A., Rivera, D. M., Galvis, J. C., & Marquez, J. C. (2019). Cystic trigeminal schwannomas. Radiology case reports, 14(12), 1513–1517. doi:10.1016/j.radcr.2019.09.031.

Swami, P., Raval, R., Kumawat, V., & Nyklesh, V. (2019). Maxillary schwannoma - A case report of a rare tumor. National Journal of Maxillofacial Surgery, 10(2), 245–248. doi:10.4103/njms.NJMS_1_16.

Zheng, X., Guo, K., Wang, H., Li, D., Wu, Y., Ji, Q., Shen, Q., Sun, T., Xiang, J., Zeng, W., Chen, Y., & Wang, Z. (2017). Extracranial schwannoma in the carotid space: A retrospective review of 91 cases. Head & Neck, 39(1), 42–47. doi:10.1002/hed.24523.

Mankin, H. J., & Mankin, K. P. (2014). Schwannoma: a rare benign tumor of soft tissues. Musculoskeletal Surgery, 98(2), 95–99. doi:10.1007/s12306-014-0333-0.

Ilagan, C., Poliakin, L., Asarian, A., Xiao, P., & Sirsi, S. (2019). Anterior knee schwannoma. Journal of Surgical Case Reports, 2019(9), rjz236. doi:10.1093/jscr/rjz236.

Scripko, P. D., Venteicher, A. S., & Plotkin, S. R. (2014). Nerve Sheath Tumors. In Encyclopedia of the Neurological Sciences (pp. 346-349). Elsevier Inc.. doi:10.1016/B978-0-12-385157-4.00488-7.

Baccon, J., Wellons, J. C., & Rizk, E. B. (2015). Pediatric peripheral nerve tumors. In Nerves and nerve injuries (pp. 839-846). Academic Press. doi:10.1016/B978-0-12-802653-3.00102-0.

Jiang, S., Shen, H., & Lu, H. (2019). Multiple schwannomas of the digital nerves and common palmar digital nerves: An unusual case report of multiple schwannomas in one hand. Medicine, 98(10), e14605. doi:10.1097/MD.0000000000014605.

He, Y. A., Yan, C., Chen, Y., Zhu, L. G., Cai, M., & Wang, W. T. (2020). Management of Schwannoma in the hepatoduodenal ligament: A case report and review of the literature. Medicine, 99(3), e18797. doi:10.1097/MD.0000000000018797.

Saggini, A., Di Prete, M., D'Amico, F., Lora, V., & Orlandi, A. (2019). Glandular Schwannoma: An Uncommon Variant of Schwannoma with Controversial Histogenesis. Dermatopathology (Basel, Switzerland), 6(4), 206–212. doi:10.1159/000503599.

Hide, I. G., Baudouin, C. J., Murray, S. A., & Malcolm, A. J. (2000). Giant ancient schwannoma of the pelvis. Skeletal Radiology, 29(9), 538-542. doi:10.1007/s002560000266.

Isobe, K., Shimizu, T., Akahane, T., & Kato, H. (2004). Imaging of ancient schwannoma. AJR. American Journal of Roentgenology, 183(2), 331–336. doi:10.2214/ajr.183.2.1830331.

Choudry, H. A., Nikfarjam, M., Liang, J. J., Kimchi, E. T., Conter, R., Gusani, N. J., & Staveley-O'Carroll, K. F. (2009). Diagnosis and management of retroperitoneal ancient schwannomas. World Journal of Surgical Oncology, 7, 12. doi:10.1186/1477-7819-7-12.

Malizos, K., Ioannou, M., & Kontogeorgakos, V. (2013). Ancient schwannoma involving the median nerve: a case report and review of the literature. Strategies in Trauma and Limb Reconstruction, 8(1), 63–66. doi: 10.1007/s11751-013-0158-7.

Schaberg K., Born D., Robert V Rouse R.V. (2015). Surgical pathology criteria: Schwanoma. Stanford Medicine. Available online: (accessed on December 2020).

Al-Shudifat, A., Mafrachi, B., Al-Ani, A., Qaisi, A., & Bustami, N. (2020). Ancient Schwannoma affecting the intracranial portion of the trigeminal nerve: A case report. Surgical Neurology International, 11, 426. doi:10.25259/SNI_464_2020.

Wierzbicki, V., Pesce, A., Marrocco, L., Piccione, E., Frati, A., & Caruso, R. (2016). Ancient Schwannoma of the Cauda Equina: Our Experience and Review of the Literature. Case Reports in Surgery, 2016, 7930521. doi:10.1155/2016/7930521.

Woodruff, J. M., Godwin, T. A., Erlandson, R. A., Susin, M., & Martini, N. (1981). Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. The American Journal of Surgical Pathology, 5(8), 733–744. PMID: 7337161.

Alam, K., Jain, A., & Misra, A. (2013). Cellular schwannoma masquerading as malignant peripheral nerve sheath tumour: a diagnostic dilemma. Case Reports, 2013, bcr2012008435. doi:10.1136/bcr-2012-008435.

Kim, E. R., Choi, E. O., Lee, K. B., Kang, C. H., Kim, Y. T., & Park, I. K. (2014). A recurrent cellular schwannoma. The Korean Journal of Thoracic and Cardiovascular Surgery, 47(5), 487. doi:10.5090/kjtcs.2014.47.5.487.

Alberghini, M., Zanella, L., Bacchini, P., & Bertoni, F. (2001). Cellular schwannoma: a benign neoplasm sometimes overdiagnosed as sarcoma. Skeletal Radiology, 30(6), 350-353. doi:10.1007/s002560100356.

Koyye, R. T., Mahadevan, A., Santosh, V., Chickabasaviah, Y. T., Govindappa, S. S., Hegde, T., & Shankar, S. K. (2003). A rare case of cellular schwannoma involving the trigeminal ganglion. Brain Tumor Pathology, 20(2), 79-83. doi:10.1007/BF02483451.

Landeiro, J. A., Ribeiro, C. H., Galdino, A. C., Taubman, E., & Guarisch, A. J. (2003). Cellular schwannoma: a rare spinal benign nerve-sheath tumor with a pseudosarcomatous appearance: case report. Arquivos de Neuro-psiquiatria, 61(4), 1035-1038. doi:10.1590/s0004-282x2003000600029.

Laforga, J. B. (2003). Cellular schwannoma: report of a case diagnosed intraoperatively with the aid of cytologic imprints. Diagnostic Cytopathology, 29(2), 95-100. doi:10.1002/dc.10314.

Pekmezci, M., Reuss, D. E., Hirbe, A. C., Dahiya, S., Gutmann, D. H., Von Deimling, A., & Perry, A. (2015). Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Modern Pathology, 28(2), 187-200. doi:10.1038/modpathol.2014.109.

D'Almeida Costa, F., Dias, T. M., Lombardo, K. A., Raghunathan, A., Giannini, C., Kenyon, L., & Rodriguez, F. J. (2020). Intracranial cellular schwannomas: a clinicopathological study of 20 cases. Histopathology, 76(2), 275-282. doi:10.1111/his.13967.

Al-Otieschan, A. T., Manohar, M. B., Gangopadhyay, K., & Tulbah, A. (2002). Cellular schwannoma of the paranasal sinuses: initial report of a case. Ear, Nose & Throat Journal, 81(4), 281-284. doi:10.1177/014556130208100418.

Zhang, S., Wang, X., Zhang, Z., & Chen, Y. (2008). Tanycytic ependymoma arising from the right lateral ventricle: A case report and review of the literature. Neuropathology, 28(4), 427–432. doi:10.1111/j.1440-1789.2007.00857.x.

Patocskai, E. J., Tabatabaian, M., & Thomas, M. J. (2002). Cellular schwannoma: a rare presacral tumour. Canadian Journal of Surgery, 45(2), 141. PMID: 11939658.

Kang, S. K., Chang, S. E., Choi, J. H., Sung, K. J., Moon, K. C., & Koh, J. K. (2002). A case of cellular schwannoma of the skin presenting as a large ulcerated tumor on the ankle. The Journal of Dermatology, 29(1), 28-32. doi:10.1111/j.1346-8138.2002.tb00161.x.

Chandran, R. S., Patil, A. K., Prabhakar, R. B., & Balachandran, K. (2018). Melanotic schwannoma of spine: illustration of two cases with diverse clinical presentation and outcome. Asian Journal of Neurosurgery, 13(3), 881. doi:10.4103/ajns.AJNS_353_16.

Mahato, D., Vivas-Buitrago, T., Gassie, K., Jentoft, M., Tavanaiepour, D., & Quinones-Hinojosa, A. (2018). Intracranial melanotic schwannomas: a rare variant with unusual adherent features. Journal of Neuro-oncology, 136(2), 299-306. doi:10.1007/s11060-017-2653-z.

Spina, A., Gagliardi, F., Boari, N., Terreni, M. R., & Mortini, P. (2015). Intracranial melanotic schwannomas. Journal of Neurological Surgery Part A: Central European Neurosurgery, 76(05), 399-406. doi:10.1055/s-0034-1393926.

Alexiev, B. A., Chou, P. M., & Jennings, L. J. (2018). Pathology of melanotic schwannoma. Archives of Pathology & Laboratory Medicine, 142(12), 1517-1523. doi:10.5858/arpa.2017-0162-RA.

Culhaci, N., Dikicioĝlu, E., Meteoğlu, I., & Boylu, Ş. (2003). Multiple melanotic schwannoma. Annals of Diagnostic Pathology, 7(4), 254-258. doi:10.1016/s1092-9134(03)00073-x.

Kurtkaya-Yapicier, O., Scheithauer, B. W., & Woodruff, J. M. (2003). The pathobiologic spectrum of Schwannomas. Histology and Histopathology, 18: 925-934. doi:10.14670/HH-18.925.

Li, X. L., & Dai, S. D. (2019). Melanotic Schwannoma: two cases of rare lesions. Pathology & Oncology Research, 25(4), 1667-1670. doi:10.1007/s12253-018-0417-5.

Akiyoshi, T., Ueda, Y., Yanai, K., Yamaguchi, H., Kawamoto, M., Toyoda, K., & Ohuchida, J. (2004). Melanotic schwannoma of the pancreas: report of a case. Surgery Today, 34(6), 550-553. doi:10.1007/s00595-004-2744-2.

Er, U., Kazanci, A., Eyriparmak, T., Yigitkanli, K., & Senveli, E. (2007). Melanotic schwannoma. Journal of Clinical Neuroscience, 14(7), 676-678. doi:10.1016/j.jocn.2006.03.010.

Küsters-Vandevelde, H. V., van Engen-van Grunsven, I. A., Küsters, B., van Dijk, M. R., Groenen, P. J., Wesseling, P., & Blokx, W. A. (2010). Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis. Acta Neuropathologica, 120(6), 755-764. doi:10.1007/s00401-010-0749-z.

Choi, S. E., Cha, Y. J., Kim, J., Cha, H., Seo, J., Kuh, S. U., & Kim, S. H. (2017). A rare case of aggressive melanotic schwannoma occurred in spinal nerve of a 59-year-old male. Journal of Pathology and Translational Medicine, 51(5), 505. doi:10.4132/jptm.2017.01.04.

Matsuoka, Y., Kakudo, N., Fukui, M., & Kusumoto, K. (2019). Giant plexiform schwannoma in the plantar aspect of the foot: a case report. Journal of Surgical Case Reports, 2019(11), rjz352. doi:10.1093/jscr/rjz352.

Jacobson, J. M., Felder III, J. M., Pedroso, F., & Steinberg, J. S. (2011). Plexiform schwannoma of the foot: a review of the literature and case report. The Journal of Foot and Ankle Surgery, 50(1), 68-73. doi:10.1053/j.jfas.2010.07.002.

Mohammed, S. A., Pressman, M. M., Schmidt, B., & Babu, N. (2014). Case presentations and review of plexiform schwannoma in the foot. The Journal of Foot and Ankle Surgery, 53(2), 179-185. doi:10.1053/j.jfas.2013.12.020.

Destro, F., Sharma, S., Maestri, L., Vella, C., Collini, P., & Riccipetitoni, G. (2021). Visceral plexiform schwannoma: A case series. Molecular and Clinical Oncology, 14(1), 1-1. doi:10.3892/mco.2020.2176.

Berg, J. C., Scheithauer, B. W., Spinner, R. J., Allen, C. M., & Koutlas, I. G. (2008). Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. Human Pathology, 39(5), 633-640. doi:10.1016/j.humpath.2007.10.029.

Talwalkar, S. C., Cutler, L., & Stilwell, J. H. (2005). Multiple plexiform schwannoma of the hand and forearm: a long-term follow-up. Journal of Hand Surgery, 30(4), 358-360. doi:10.1016/j.jhsb.2005.04.008.

Lambade, P. N., Lambade, D., Saha, T. K., Dolas, R. S., & Dhobley, A. (2013). Unusual intramaxillary plexiform schwannoma. Oral and Maxillofacial Surgery, 17(2), 137-140. doi:10.1007/s10006-012-0345-6.

Hart, J., Gardner, J. M., Edgar, M., & Weiss, S. W. (2016). Epithelioid schwannomas. The American Journal of Surgical Pathology, 40(5), 704-713. doi:10.1097/PAS.0000000000000589.

Jo, V. Y., & Fletcher, C. D. (2017). SMARCB1/INI1 loss in Epithelioid Schwannoma. The American Journal of Surgical Pathology, 41(8), 1013-1022. doi:10.1097/PAS.0000000000000849.

Chan, A. W., Mak, S. M., & Chan, G. P. (2011). Benign epithelioid schwannoma of intraparotid facial nerve. Pathology, 43(3), 280–282. doi:10.1097/PAT.0b013e3283437cc0.

Krishnamurthy, T., & SR Niveditha MD, D. N. B. (2014). Benign epithelioid peripheral nerve sheath tumour resembling schwannoma. The Malaysian Journal of Pathology, 36(3), 217. PMID: 25500523.

Yuen, T., & Kaye, A. H. (2004). Intracranial epithelioid schwannoma–a case report. Journal of Clinical Neuroscience, 11(1), 91-95. doi:10.1016/s0967-5868(03)00114-0.

Fisher, B. J., & Dennis, K. E. (2006). Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response. Journal of Neuro-oncology, 78(2), 173-177. doi:10.1007/s11060-005-9083-z.

Neurosurgery. (2018). Spinal Schwannoma Classification. Neurosurgery directory. Available online: (accessed on December 2020).

Scheithauer, B. W., Woodruff, J. M., & Spinner, R. J. (2010). Peripheral nerve sheath tumors. Practical Surgical Neuropathology. Philadelphia: Elsevier, 235-85. doi:10.1016/B978-0-443-06982-6.00012-2.

Yoon, J., Cusimano, M., & Munoz, D. G. (2019). Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing. Journal of Clinical Neuroscience, 66, 231-234. doi:10.1016/j.jocn.2019.05.002.

Yau, W. H., & Ameratunga, M. (2020). Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma. Journal of clinical Pharmacy and Therapeutics, 45(5), 1172–1174. doi:10.1111/jcpt.13112.

Mansour, S., Luther, E., Eichberg, D. G., Shah, A., Echeverry, N., Humayun Gultekin, S., Ivan, M., & Komotar, R. (2020). Multifocal Intracranial Ganglioglioma in a Sexagenarian: Case Report and Review of the Current Literature. World Neurosurgery, 138, 498–503. doi:10.1016/j.wneu.2019.12.084.

Mpairamidis, E., Alexiou, G. A., Stefanaki, K., Sfakianos, G., & Prodromou, N. (2008). Brainstem ganglioglioma. Journal of Child Neurology, 23(12), 1481–1483. doi:10.1177/0883073808319316.

Im, S. H., Chung, C. K., Cho, B. K., Wang, K. C., Yu, I. K., Song, I. C., Cheon, G. J., Lee, D. S., Kim, N. R., & Chi, J. G. (2002). Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. Journal of Neuro-oncology, 59(2), 173–183. doi:10.1023/a:1019661528350.

Pujadas, E., Chen, L., & Rodriguez, F. J. (2019). Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors. Brain Tumor Pathology, 36(2), 40–51. doi:10.1007/s10014-019-00336-z.

Lisievici, A. C., Georgescu, T. A., Pasov, D., Tascu, A., Lisievici, M. G., & Sajin, M. (2018). Grading Gangliogliomas: a Short Case Series with Clinico-Imagistic and Immunohistopathological Correlations. Maedica, 13(3), 241-249. doi:10.26574/maedica.2018.13.3.241.

Majores, M., von Lehe, M., Fassunke, J., Schramm, J., Becker, A. J., & Simon, M. (2008). Tumor recurrence and malignant progression of gangliogliomas. Cancer, 113(12), 3355–3363. doi:10.1002/cncr.23965.

Yoon, J., Cusimano, M., & Munoz, D. G. (2019). Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing. Journal of Clinical Neuroscience, 66, 231-234. doi:10.1016/j.jocn.2019.05.002.

Prasad, G. L., Kumar, R., Kurwale, N., & Suri, V. (2016). Intraventricular Gangliogliomas: A Review. World Neurosurgery, 87, 39–44. doi:10.1016/j.wneu.2015.11.044.

Odia, Y. (2016). Gangliocytomas and gangliogliomas: review of clinical, pathologic and genetic features. Clinics in Oncology, 1.

Blümcke, I., Coras, R., Wefers, A. K., Capper, D., Aronica, E., Becker, A., Honavar, M., Stone, T. J., Jacques, T. S., Miyata, H., Mühlebner, A., Pimentel, J., Söylemezoğlu, F., & Thom, M. (2019). Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype-phenotype analysis. Neuropathology and Applied Neurobiology, 45(2), 95–107. doi:10.1111/nan.12522.

Matsumoto, K., Tamiya, T., Ono, Y., Furuta, T., Asari, S., & Ohmoto, T. (1999). Cerebral gangliogliomas: clinical characteristics, CT and MRI. Acta Neurochirurgica, 141(2), 135–141. doi:10.1007/s007010050277.

Brat, D. J., Parisi, J. E., Kleinschmidt-DeMasters, B. K., Yachnis, A. T., Montine, T. J., Boyer, P. J., Powell, S. Z., Prayson, R. A., McLendon, R. E., & Neuropathology Committee, College of American Pathologists (2008). Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Archives of Pathology & Laboratory Medicine, 132(6), 993–1007. doi:10.1043/1543-2165(2008)132[993:SNUARO]2.0.CO;2.

Martínez-Ricarte, F., Martínez-Saez, E., Cicuendez, M., Cordero, E., Auger, C., Toledo, M. (2016). Atypical ganglioglioma with BRAF V600E mutation: a case report and review of the literature. Revista de neurologia, 62(10), 455-459. PMID: 27149188.

Slegers, R. J., & Blumcke, I. (2020). Low-grade developmental and epilepsy associated brain tumors: a critical update 2020. Acta Neuropathologica Communications, 8(1), 27. doi:10.1186/s40478-020-00904-x.

Kuten, J., Kaidar-Person, O., Vlodavsky, E., Postovsky, S., Billan, S., Kuten, A., & Bortnyak-Abdah, R. (2012). Anaplastic ganglioglioma in the spinal cord: case report and literature review. Pediatric Neurosurgery, 48(4), 245–248. doi:10.1159/000348556.

Khan, A., Sadek, A. R., Fabian, M., & Nader-Sepahi, A. (2020). Spinal anaplastic ganglioglioma. British Journal of Neurosurgery, 1–4. Advance online publication. doi:10.1080/02688697.2020.1823936.

Lee, C. C., Wang, W. H., Lin, C. F., Chen, H. H., Chen, S. C., Lin, S. C., & Hsu, S. P. (2012). Malignant transformation of supratentorial ganglioglioma. Clinical Neurology and Neurosurgery, 114(10), 1338-1342. doi:10.1016/j.clineuro.2012.03.018.

Zanello, M., Pages, M., Tauziède-Espariat, A., Saffroy, R., Puget, S., Lacroix, L. & Varlet, P. (2016). Clinical, imaging, histopathological and molecular characterization of anaplastic ganglioglioma. Journal of Neuropathology & Experimental Neurology, 75(10), 971-980. doi:10.1093/jnen/nlw074.

Southwell, D. G., Garcia, P. A., Berger, M. S., Barbaro, N. M., & Chang, E. F. (2012). Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery, 70(6), 1406-1414. doi:10.1227/NEU.0b013e3182500a4c.

Jane, J. A., & Laws, E. R. (2006). Craniopharyngioma. Pituitary, 9(4), 323-326. doi:10.1007/s11102-006-0413-8.

Ramanbhavana, V. S., & Vara Prasad, K. S. (2019). A Case Series of Craniopharyngioma: Epidemiological Study and Management Analysis at Tertiary Care Center. Asian Journal of Neurosurgery, 14(4), 1196–1202. doi:10.4103/ajns.AJNS_67_19.

Hengartner, A. C., Prince, E., Vijmasi, T., & Hankinson, T. C. (2020). Adamantinomatous craniopharyngioma: moving toward targeted therapies. Neurosurgical Focus, 48(1), E7. /doi:10.3171/2019.10.FOCUS19705.

Rutenberg, M. S., Rotondo, R. L., Rao, D., Holtzman, A. L., Indelicato, D. J., Huh, S. (2020). Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. Journal of Neuro-oncology, 1-9. doi:10.1007/s11060-020-03432-9.

Moszczyńska, E., Prokop-Piotrkowska, M., Bogusz-Wójcik, A., Grajkowska, W., Szymańska, S., & Szalecki, M. (2020). Ki67 as a prognostic factor of craniopharyngioma’s recurrence in paediatric population. Child's Nervous System, 1-9. doi:10.1007/s00381-020-04519-4.

Jensterle, M., Jazbinsek, S., Bosnjak, R., Popovic, M., Zaletel, L. Z., Vesnaver, T. V., & Kotnik, P. (2019). Advances in the management of craniopharyngioma in children and adults. Radiology and Oncology, 53(4):388-396. doi:10.2478/raon-2019-0036.

Müller, H. L. (2014). Craniopharyngioma. Endocrine Reviews, 35(3), 513-543. doi:10.1210/er.2013-1115.

Lubuulwa, J., & Lei, T. (2016). Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review. Journal of Neurological Surgery Reports, 77(3), e121–e127. doi:10.1055/s-0036-1588060.

Karavitaki, N., & Wass, J. A. (2008). Craniopharyngiomas. Endocrinology and Metabolism Clinics of North America, 37(1), 173-193. doi:10.1016/j.ecl.2007.10.012.

Cojocaru, E., Mihăilă, D., Leon-Constantin, M. M., Cobzaru, R. G., Rîpă, C. V., Trandafirescu, M. F., & Trandafir, L. M. (2019). Update in pediatric primary brain tumors-from histology to genetically defined tumors. Romanian journal of morphology and embryology. Revue roumaine de morphologie et embryologie, 60(3), 761-767. PMID: 31912084.

Brastianos, P. K., & Santagata, S. (2016). ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. European Journal of Endocrinology, 174(4), R139–R144. doi:10.1530/EJE-15-0957.

Whelan, R., Prince, E., Gilani, A., & Hankinson, T. (2020). The Inflammatory Milieu of Adamantinomatous Craniopharyngioma and Its Implications for Treatment. Journal of Clinical Medicine, 9(2), 519. doi:10.3390/jcm9020519.

Gupta, S., Bi, W. L., Larsen, A. G., Al-Abdulmohsen, S., Abedalthagafi, M., & Dunn, I. F. (2018). Craniopharyngioma: a roadmap for scientific translation. Neurosurgical Focus, 44(6), E12. doi:10.3171/2018.3.FOCUS1861.

Borrill, R., Cheesman, E., Stivaros, S., Kamaly-Asl, I. D., Gnanalingham, K., & Kilday, J. P. (2019). Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature. Child's Nervous System, 35(1), 169-173. doi:10.1007/s00381-018-3925-4.

Juratli, T. A., Jones, P. S., Wang, N., Subramanian, M., Aylwin, S., Odia, Y., Rostami, E., Gudjonsson, O., Shaw, B. L., Cahill, D. P., Galanis, E., Barker, F. G., 2nd, Santagata, S., & Brastianos, P. K. (2019). Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer, 125(17), 2910–2914. doi:10.1002/cncr.32197.

Karavitaki, N. (2014). Management of craniopharyngiomas. Journal of Endocrinological Investigation, 37(3), 219-228. doi:10.1007/s40618-013-0050-9.

Omay, S. B., Chen, Y. N., Almeida, J. P., Ruiz-Treviño, A. S., Boockvar, J. A., Stieg, P. E. (2017). Do craniopharyngioma molecular signatures correlate with clinical characteristics?. Journal of Neurosurgery, 128(5), 1473-1478. doi:10.3171/2017.1.JNS162232.

O'steen, L., & Indelicato, D. J. (2018). Advances in the management of craniopharyngioma. F1000Research, 7, F1000 Faculty Rev-1632. doi:10.12688/f1000research.15834.1.

Garnett, M. R., Puget, S., Grill, J., & Sainte-Rose, C. (2007). Craniopharyngioma. Orphanet Journal of Rare Diseases, 2(1), 1-7. doi:10.1186/1750-1172-2-18.

Full Text: PDF

DOI: 10.28991/SciMedJ-2021-0304-8


  • There are currently no refbacks.

Copyright (c) 2021 Brian Thabile Flepisi, Marissa Balmith